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ttp://dx.doi.org/10.1016/j.ajpath.2012.09.010Bacteria in the gut microbiome shed microbial-associated molecule patterns (MAMPs) into the portal
venous circulation, where they augment various aspects of systemic immunity via low-level stimulation.
Because the liver is immediately downstream of the intestines, we proposed that gut-derived MAMPs
shape liver immunity and affect Kupffer cell (KC) phenotype. Germ-free (GF), antibiotic-treated (AVMN),
and conventional (CL) mice were used to study KC development, function, and response to the
signiﬁcant stress of cold storage, reperfusion, and orthotopic transplantation. We found that a cocktail
of physiologically active MAMPs translocate into the portal circulation, with ﬂagellin (Toll-like receptor
5 ligand) being the most plentiful and capable of promoting hepatic monocyte inﬂux in GF mice. In
MAMP-deﬁcient GF or AVMN livers, KCs are lower in numbers, have higher phagocytic activity, and have
lower major histocompatibility complex II expression. MAMP-containing CL livers harbor signiﬁcantly
increased KC numbers via induction of intercellular adhesion molecule 1 on liver sinusoidal endothe-
lium. These CL KCs have a primed yet expected phenotype, with increased major histocompatibility
complex class II and lower phagocytic activity that increases susceptibility to liver preservation/
reperfusion injury after orthotopic transplantation. The KC number, functional activity, and matura-
tional status are directly related to the concentration of gut-derived MAMPs and can be signiﬁcantly
reduced by broad-spectrum antibiotics, thereby affecting susceptibility to injury. (Am J Pathol 2013,
182: 180e191; http://dx.doi.org/10.1016/j.ajpath.2012.09.010)Supported by NIH/National Institute of Diabetes and Digestive and
Kidney Diseases grants F31DK089902-01 (N.C.) and PO1 A1081678
(A.J.D.), the Thomas E. Starzl Transplant Endowment Fund (A.J.D.), and
University of North Carolina grant P30 DK34987, Center for Gastroin-
testinal Biology and Disease (CGIBD) core support. Cl2MDP was a gift
from Roche Diagnostics GmbH (Mannheim, Germany).More than 100 trillion, largely colon-restricted, autochtho-
nous bacteria comprise the gut microbiome.1 They not only
help shape gut morphologic features and mucosal immu-
nity2 but also contribute to the development of the extra-
intestinal immune system. For example, germ-free (GF)
rodents exhibit smaller, less cellular spleens and lower
systemic antibody levels,3 and the gut-derived microbe-
associated molecular pattern (MAMP) peptidoglycan (PDG)
can prime the systemic innate immunity.4 Extraintestinal
effects of the gut microbiome are thought to be mediated by
MAMPs, which are recognized by germline encoded pattern
recognition receptors (PRRs) expressed on cells throughoutstigative Pathology.
.the body, including Kupffer cells (KCs), hepatocytes, and
liver sinusoidal endothelial cells (LSECs).5
Gut-derived MAMPs reach the liver via blood from the
portal vein and ﬁrst encounter PRR-bearing KCs, the most
abundant of all tissue macrophage populations, and sinu-
soidal endothelium. Despite a valid assumption that
MAMPs Drive Kupffer Cell AccumulationMAMPs reach the liver via the portal venous blood, the
relative physiologic composition of various portal venous
MAMPs under homeostatic conditions and their effects, if
any, on LSEC and KC populations, including their physi-
ologic activation/maturation state, are poorly understood.
Interactions among gut-derived MAMPs, LSECs, and KCs,
however, have the potential to control KC activation status
and signaling pathways and trigger protein secretion that
can profoundly inﬂuence all nearby cells, including hepa-
tocytes, stellate cells, LSECs, and intrahepatic leukocytes.
Consequently, gut-derived MAMP interactions with LSECs
and KCs can signiﬁcantly inﬂuence susceptibility to injury
and hepatic physiologic and pathophysiologic responses to
environmental challenges. Included are host defense,
regeneration, ﬁbrogenesis, carcinogenesis, toxin exposure,
ischemia/reperfusion injury, and immunologic tolerance.6
Particular bacterial species (ie, Clostridium species,
segmented ﬁlamentous bacteria) and speciﬁc MAMPs (ie,
polysaccharide A, PDG) can induce the development of
lymphoid tissue and immune cell subsets within the gut,2 and
MAMPs translocate to the liver via portal circulation under
homeostatic conditions. Therefore, we tested the hypothesis
that gut bacteria orchestrate the development of the normal
KC population of the liver and, in turn, help determine the
susceptibility to injury and response to environmental chal-
lenges. Results indicate that the number and activation/
maturational status of KCs directly correlate with density of
gut bacteria and susceptibility to injury, as indicated by the
extent of cold preservation/reperfusion injury after orthotopic
liver transplantation. This is mediated via gut-derived
MAMPs that increase LSEC intercellular adhesion mole-
cule 1 (ICAM-1) and lymphatic vessel endothelial receptor
1 (LYVE-1) expression, which in turn recruit KCs from
circulating KC progenitors. Most importantly, broad-
spectrum antibiotic therapy can decrease both the gut
microbiome and liver KC population, which in turn inﬂu-
ences a wide variety of hepatic immunology, drug reactions,
physiologic processes, and susceptibility to injury.
Materials and Methods
Animals
All mice received humane care according to the guidelines
in the Guide for the Care and Use of Laboratory Animals.
Procedures performed on animals were approved by the
University of Pittsburgh’s Institutional Animal Care and
Use Committee protocols 1001281B-4 and 1002448. GF
and conventional (CL) Swiss Webster male mice aged 3 to 4
weeks or 6 to 9 weeks were purchased from Taconic (New
York, NY) and the Center for Gastrointestinal Biology and
Disease Core at the University of North Carolina (Chapel
Hill, NC). GF mice were maintained inside of a sterile vinyl
isolator for 48 hours with sterilized food and water. CL mice
were maintained under speciﬁc pathogen-free conditions.
To generate the antibiotic-treated (AVMN) experimentalThe American Journal of Pathology - ajp.amjpathol.orggroups for various experiments, antibiotics (ampicillin, 1 g/L;
vancomycin, 0.5 g/L; metronidazole, 1 g/L; and neomycin,
1 g/L) were delivered to CL mice (4 to 10 weeks old) in
drinking water (changed every 3 days) for 2.4 to 7 weeks,
depending on body weight minimums needed for trans-
plantation. All mice, however, were 11 to 13 weeks old at the
time of transplantation.
The second group was given antibiotics later so treatment
time could be reduced to 2 weeks (not to risk bacterial
overgrowth by resistant strains and still reach optimal body
weight for successful transplantation).Cell Preparations
Livers were perfused with cold Hanks’ balanced salt solu-
tion and digested with collagenase (2 mg). Perfused livers
were placed in a 1:1 solution of cold PBS (Invitrogen, San
Diego, CA) and RPMI 1640 (Sigma-Aldrich, The Wood-
lands, TX) supplemented with 5% fetal bovine serum,
nonessential amino acids, sodium pyruvate, HEPES,
L-glutamine, b-mercaptoethanol, and penicillin/strepto-
mycin (Invitrogen). For in vivo challenge experiments,
nonparenchymal cells (NPCs) were suspended in cold
RPMI only. Livers were minced through a cell dissociation
sieve (size 40; Sigma-Aldrich) for single cell suspension,
separated into hepatocytes and NPC by centrifugation
(60  g), ﬁltered three times (40 mm cell strainer; BD
Falcon, Franklin Lakes, NJ), and stained for ﬂow cytometry
(FC). More than 85% of isolated NPCs were CD45þ
(CD45-Alexaﬂuor700; Biolegend, San Diego, CA).
Peripheral blood mononuclear cells (PBMCs) were ob-
tained from systemic blood suspended in 2 mL of Hanks’
balanced salt solution for Ficoll (Invitrogen) gradient sepa-
ration. The buffy coat was removed, washed, ﬁltered
(40-mm cell strainer; BD Falcon), and stained for FC.
Bone marrow was ﬂushed using a 1:1 solution of PBS
and RPMI Complete Media. Bone marrow derived cells
(BMDCs) were washed, ﬁltered (40-mm cell strainer; BD
Falcon), and stained for FC.Flow Cytometry
Cells were resuspended in FACS buffer (1% bovine serum
albumin, 0.1% sodium azide in PBS). Cells were analyzed
on a BD LSR II with FACS Diva software version 6.1.3. FC
data were analyzed with Flow Jo (Tree Star Inc., Ashland,
OR). The antibodies used are listed in Table 1.Stool Isolation and Bacterial Detection
Total DNA was extracted from 80 mg of cecal stool using
a QIAmp DNA stool mini-kit (Qiagen, Santa Clarita, CA).
Extracted DNA was submitted to real-time PCR of the
conservedregionofthebacterial16SrRNAgeneusinguniversal
primers (forward 50-TCCTACGGGAGGCAGCAGT-30 and181
Table 1 List of Antibodies Used in the Study
Antigen Host (isotype) Clone Source
Flow cytometry
Gr1 (Ly6G) Rat (IgG2b, k) RB6-8C5 eBioscience
(San Diego,
CA)
F4/80 Rat (IgG2a, k) BM8 eBioscience
CD11b Rat (IgG2b, k) M1/70 Biolegend
MHCII (I-A/I-E) Rat (IgG2b, k) M5/114.15.2 eBioscience
CD80 (B7-1) Armenian
Hamster (IgG)
16-10A1 eBioscience
CD86 (B7-2) Rat (IgG2a, k) GL1 eBioscience
Ly6C Rat (IgG2c, k) HK1.4 Biolegend
CD281 (TLR1) Rat (IgG2a, k) eBioTR23 eBioscience
CD282 (TLR2) Rat (IgG2b, k) 6C2 eBioscience
TLR4/MD2
complex
Rat (IgG2a, k) MTS510 eBioscience
CD289 (TLR9) Rat (IgG2a) M9.D6 eBioscience
TLR5 Mouse
(IgG2a, k)
19D759.2 Imgenex
(San Diego,
CA)
CD16/CD32
(Fc block)
Rat (IgG2a, l) 93 eBioscience
Tissue staining
F4/80 Rat (IgG2b) CI:A3-1 AbD Serotec
(Raleigh, NC)
ICAM-1 (CD54) Armenian
Hamster
(IgG1, k)
3E2 BD Pharmingen
(Franklin
Lakes, NJ)
CD44 (LYVE1) Rat (IgG1) ALY7 eBioscience
Ki67 Rabbit SP6 GeneTex
(Irvine, CA)
Corbitt et alreverse 50-GGACTACCAGGGTATCTAATCCTGTT-30) as
described byNadkarni et al.7 To calibrate the quantitative real-
time PCR (qPCR) reaction, DNA from Escherichia coli
(maximum efﬁciency DH5a competent cells; Invitrogen) was
used. Ampliﬁcation and detection of DNA by qPCR were
performed with the 7500 Fast Real-Time PCR Instrument
(Applied Biosystems, Foster City, CA). Enumeration of
bacteria was also performed using the Bacteria Counting Kit
for Flow Cytometry (B-7277; Invitrogen) according to the
manufacturer instructions.
Tissue Staining and Image Analysis
Formalin-ﬁxed, parafﬁn-embedded, and OCT embedded
tissue was sectioned (4 mm) and stained with the antibodies
listed in Table 1. For immunoﬂuorescence, Qdot streptavidin
conjugates (Invitrogen) were used after application of bio-
tinylated hamster secondary (BD Pharmingen, Franklin
Lakes, NJ) or biotinylated rat and rabbit secondary (Vector
Laboratories, Burlingame, CA) antibodies. Images were
captured using the Mirax MIDI Whole Slide Scanner (Zeiss,
Thornwood,NY). Quantitative image analysis was completed
using internally developed NearCYTE software (http://www.182nearcyte.org) with KCs deﬁned as nucleated F4/80þ cells and
normalized to a standard tissue area in 4-mm sections.
Western Blotting
Protein was isolated from CL, GF, and AVMN livers by
tissue homogenization in RIPA buffer containing complete
protease inhibitors (Roche Applied Science, Indianapolis,
IN). Protein quantiﬁcation was assessed with a BCA Protein
Assay Kit (Pierce, Chicago, IL). Seventy-ﬁve micrograms of
protein was run on SDS-PAGE. After electrotransfer to
a nitrocellulose membrane, 5% milk in Tris buffered saline
Tween was used for blocking, and monoclonal b-actin (clone
AC-15; Sigma-Aldrich) and ICAM-1 (clone M19; Santa
Cruz Biotechnology, Santa Cruz, CA) were used to probe the
membrane. ECL Western blotting substrate (Thermo Scien-
tiﬁc, Ashville, NC) was used to visualize the protein.
RNA Isolation, RT-PCR, and PCR for Murine Genes
Total RNA was extracted from homogenized liver tissue
using Trizol (Invitrogen). Reverse transcription was per-
formed using High Capacity RNA-to-cDNA Master Mix
(Applied Biosystems) according to the manufacturer
instructions. To determine expression of Csf1 and Csf2
relative to the Hprt internal control, 25 ng of cDNA was
used in a 10-mL reaction using the Taqman Fast Universal
PCR Master Mix (Applied Biosystems) and Taqman array
96 well fast plates for mouse immune response (Applied
Biosystems). Analysis was performed on a 7500 Fast Real-
Time PCR Instrument (Applied Biosystems).
In Vivo Phagocytosis
Mice were injected (tail vein) with sphero carboxyl magnetic
particles (1.22 mm) once (200 mL, w5.4  108 particles;
Spherotech Inc., Libertyville, IL). NPCs and active liver
phagocytes were isolated by magnetic separation. Phagocytes
were then counted and analyzed by FC.
KC Depletion and in Vivo Antibody Blockade
CL mice were treated as follows: day 0: clodronate lipo-
some injection (300 mL i.p.); day 3: blocking antibody
injection i.p. using 50 mg (100 mL) of antieICAM-1 (YN1/
1.7.4; Abcam, Cambridge, MA) and/or 20 mg (100 mL) of
anti-LYVE1 (CD44, IM7.8.1; Cedarlane, Burlington, NC).
Rat IgG2b (50 mg, 100 mL) (BD Biosciences, San Jose, CA)
was used as an isotype control; and day 6: KC repopulation
and monocyte frequency assessment by FC. Cl2MDP (or
clodronate) was a gift from Roche Diagnostics GmbH,
Mannheim, Germany. Other reagents include phosphati-
dylcholine (LIPOID E PC; Lipoid GmbH, Ludwigshafen,
Germany), cholesterol (Sigma Chemical Co., St. Louis,
MO), and CL2MDP (laboratory of Dr. Nico van Rooijen,
Amsterdam, The Netherlands).ajp.amjpathol.org - The American Journal of Pathology
Figure 1 Gut bacteria and intestinal permeability. A: Top row: Representative images of intestines reveal cecal dilation in GF and AVMN but not in CL mice
(arrowheads).Middle row: Representative images of the isolated cecum highlight dilation in GF and AVMNmice. Bottom row: Longitudinal H&E sections of cecal
wall reveal thinned muscularis propria in GF and AVMN mice. Scale barZ 100 mm. ***P< 0.01. B: Bacterial density of cecal stool assessed by a Flow Cytometry
Bacterial Counting Kit (see Materials and Methods) conﬁrms the gut bacterial status of CL and GF mice and marked variability in CL mice (left). Bacterial DNA (in
nanograms) in cecal stool assessed by real-time PCR ampliﬁcation of 16S rRNA gene again reveals absence (GF) or marked reduction (AVMN) and considerable
variability of gut bacteria in CL mice (nZ 10) (PZ 0.05) (right). ***P < 0.005. C: PRR ligand detection in CL portal and systemic blood assessed by NF-kB
activation in HEK293 cells expressingmouse TLR-2,mouse TLR-3, mouse TLR-4/CD14/MD2,mouse TLR-5,mouse NOD1 (N1), mouse NOD2 (N2), or no PRR on NF-kB
control cells. Blood pooled from 10 CL mice; means are representative of two experiments performed in duplicate, revealing signiﬁcantly above background levels
for TLR-2, -5, and -9. *P< 0.05 compared to control (C) levels.DeF: Estimation of TLR ligand concentrations for TLR-2, TLR-5, and TLR-9 relative to known controls
in pooled plasma from CLmice.D: TLR-2 activation on HEK293 cells by no ligand (dashed line), portal blood (solid line) and heat-killed L. monocytogenes (dotted
line) at 106, 107, and 108. Blood pooled from 10mice. Samples were run in triplicate. E: TLR-5 Activation on HEK293 cells by no ligand (dashed line), portal blood
(solid line), andﬂagellin (dotted line) at 100, 10, and 1 ng/mL. F: TLR-9 activation onHEK293 cells by no ligand (dashed line), portal blood (solid line), and CpG
ODN 1826 (dotted line) at 1, 0.1, and 0.01 mg/mL.
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Corbitt et alPRR Stimulation
Flagellin (FLA-ST; Invitrogen) (dose of 100 ng, 100 mL)
was injected via tail vein into CL and GF mice. Controls
were injected with 100 mL of PBS. NPCs were isolated 24
hours after challenge.
PRR Ligand Screening
Portal and systemic blood were collected from adult CL
Swiss Webster mice. Blood plasma was collected, and
alkaline phosphatase was heat inactivated by 30-minute
incubation at 56C. Brieﬂy, Invitrogen performed PRR
ligand screening by assessing NF-kB activation in HEK293
cells expressing a single PRR. NF-kB activation was
monitored by measuring secreted alkaline phosphatase,
a reporter gene in HEK293 cells induced by NF-kB. Plasma
from CL mice was tested on nonobese diabetic (NOD) 1,
NOD2, and Toll-like receptors (TLRs) 2, 3, 4, 5, and 9
mice. Plasma was tested in duplicate using a 1:10 dilution
and compared with control ligands. The following were
used as positive controls: heat-killed Listeria mono-
cytogenes (TLR-2), poly (I:C) (TLR-3), E. coli K12 lipo-
polysaccharide (LPS) (TLR-4), Salmonella typhimurium
ﬂagellin (TLR-5), CpG ODN 1826 (TLR-9), C12-iEDAP
(NOD1), L18-MDP (NOD2), and tumor necrosis factor
a (NF-kB control cells). NF-kB control cells (no PRR) and
unstimulated PRR-expressing HEK293 cells were used as
negative controls. The results are provided as mean OD
values. For semiquantiﬁcation of ligands, plasma was
concentrated twofold for testing (Amicon Ultra 3K
Centrifugal Filters; Millipore, Marlborough, MA). Then
10-fold dilutions of plasma and positive control ligands
were tested in triplicate for activation of TLR-2, TLR-5, and
TLR-9. The upper and lower limits of detection for TLR
screening using HEK293 cells are as follows: 106 to
109 cells/mL of TLR-2 agonist heat-killed L. mono-
cytogenes or 0.01 to 10 ng/mL of Pam3CSK4, 100 pg/mL to
1 mg/mL of TLR-4 agonist LPS, and 1 ng/mL to 1 mg/mL of
TLR-9 agonist ODN 1826.
Mouse Orthotopic Liver Transplantation
Techniques of liver harvesting and orthotopic liver trans-
plantation without hepatic artery reconstruction were
based on the method of Qian et al,8 with minor modiﬁ-
cations.9,10 Liver grafts from AVMN or untreated C57Bl/
6J mice (Jackson Labs, Bar Harbor, ME) were perfused
with 5.0 mL of University of Wisconsin solution via
the inferior vena cava in a retrograde fashion, stored for
24 hours at 4C, and then implanted orthotopically into
untreated B6 mice by anastomosis of the suprahepatic
vena cava with a running 10-0 suture and anastomosis
of the portal vein and inferior vena cava using a cuff
technique. Mean  SD anhepatic time was 22.2  2.3
minutes. The bile duct was connected via ligation over the184stent. The recipient animals were euthanized 6 hours after
reperfusion for serum alanine aminotransferase and
aspartate aminotransferase determinations and graft histo-
pathologic analysis.
Statistical Analysis
Student’s t-test or U-test was used to determine signiﬁcance
between two groups. In vivo analyses were performed using
three or more animals per group. Analysis of variance was
used when comparing more than two groups. Data are
presented as the arithmetic mean. Error bars represent SEM.
All data are representative of two or more independent
experiments. For all, P < 0.05 was considered statistically
signiﬁcant.
Results
Gut Bacteria Are a Major Source of Systemic MAMPs
Gut bacteria help shape normal gut morphologic features as
evidenced by cecal dilation in GF mice, which has been
previously attributed to water and mucous accumulation and
a thinner cecal muscularis propria described by Smith et al3
(Figure 1A).
Gut microbial density increases temporally and spatially,
with the greatest bacterial loads found after weaning during
adulthood in the distal gut2 (unpublished data). Bacterial
density, however, can vary in relationship to the environ-
ment, mouse strain, sex, and age.11 Because >50% of gut
bacteria cannot be cultivated,11 we assessed cecal bacterial
density via PCR ampliﬁcation of the bacterial 16S ribo-
somal gene and via ﬂow cytometry. Cecal bacterial density
measurements revealed that adult CL mice average >12
million bacteria per gram of stool, but CL siblings housed
in the same room, cage, and speciﬁc pathogen free condi-
tions yielded a wide range of bacterial levels (Figure 1B),
likely attributable to bacterial population dynamics. As ex-
pected, cecal bacteria were undetectable in GF mice
(Figure 1B), whereas AVMN mice had an 8.5-fold reduc-
tion in bacterial DNA relative to CL mice (P Z 0.005)
(Figure 1B).
Live, whole bacterial translocation to the liver rarely
occurs under nonpathogenic homeostatic conditions12 (data
not shown), but it is widely accepted that gut-derived
MAMPs shed by commensals are able to penetrate the gut
barrier. Yet, the amalgam of functionally active MAMPs
able to translocate into portal and systemic circulation has
not been fully characterized. It is also unclear whether
physiologic levels of individual or combinations of MAMPs
exert downstream effects on the liver. Therefore, we iden-
tiﬁed gut-derived PRR ligands by screening portal and
systemic blood for MAMPs using an NF-kB activation
bioassay (Figure 1C). PRR ligation by MAMPs from portal
and systemic blood was observed for TLR-2, TLR-5, and
TLR-9 but not for TLR-3, TLR-4, NOD1, or NOD2ajp.amjpathol.org - The American Journal of Pathology
Figure 2 The gut microbiota increase mature
KC frequency and direct KC distribution. A:
Percentage of NPCs isolated from livers of adoles-
cent CL and GF mice expressing F4/80 (macro-
phage) or F4/80 and MHCII (mature macrophage)
were similar. Representative of three independent
experiments (nZ 6 in the CL group; nZ 6 in the
GF group) (F4/80þ PZ 0.40; F4/80þ MHCIIþ PZ
0.06). B: Correlative analysis revealed that mature
KC frequency (F4/80þMHCIIþ NPCs) was directly
proportional to bacterial load (nanograms of
bacterial DNA per gram of cecal stool); Pearson’s
correlation coefﬁcient Z 0.73. C: Percentage of
F4/80þ NPCs (cyan ﬁlled gate) or F4/80þMHCIIþ
NPCs (black lined gate) isolated from livers of adult
CL mice was signiﬁcantly greater than that of GF
mice (n Z 5 in the CL group; n Z 5 in the GF
group). Dot plots representative of 4 independent
experiments. D: Percentage of F4/80þ NPCs (cyan
ﬁlled gate) or F4/80þMHCIIþ NPCs (black lined
gate) isolated from livers of adult CL mice was
signiﬁcantly greater than AVMN mice (nZ 5 in the
CL group; n Z 5 in the GF). Representative of two
independent experiments. E: KC distribution in
livers of CL, GF, and AVMN mice assessed by
immunoﬂuorescence staining of liver sections with
F4/80 (green) and DAPI nuclear counterstain
(blue). Analysis was performed by tissue cytometry
(NearCYTE) (Supplemental Figure S3). Three lobular
portal areas and central areas were each randomly
selected from a total of three animals per group
and F4/80þ cell numbers/0.1 mm2 counted.
Representative images was shown in the ﬁgure.
Scale barZ 100 mm. Adult CL, GF, and AVMN mice
were used. *P < 0.05, **P < 0.025, ***P < 0.01.
MAMPs Drive Kupffer Cell Accumulation(Figure 1C). Although TLR-4 and NOD ligands (LPS and
PDG, respectively) are known to be detectable in the portal
circulation, their physiologic concentrations may not be
detectable in this bioassay or they might be in a form that
does not trigger PRR signaling. Alternatively, LPS and PDG
might be responsible for the observed TLR-2 activation
because both are known to also bind to this receptor.
We next examined NF-kB activation in response to
TLR-2 (Figure 1D), TLR-5 (Figure 1E), and TLR-9
(Figure 1F) ligation by circulating MAMPs in the portal
blood compared with concentrations of known TLR ligands
(heat-killed L. monocytogenes, ﬂagellin, and CpG, respec-
tively). Figure 1, E and F, indicate TLR-5 ligand concen-
tration (presumably ﬂagellin) ranges of 1 to 10 ng/mL andThe American Journal of Pathology - ajp.amjpathol.orgTLR-9 ligand concentration (presumably bacterial DNA)
ranges of 0.01 to 0.1 mg/mL in portal circulation. The
relative concentration of TLR-2 ligand is indeterminate
because of inﬁdelity of TLR-2 to a single ligand and
recognition of multiple fungal and bacterial MAMPs.
KC Frequency and MHCII Expression Increase with
Bacterial Density
Ligation of a PRR (NOD1) by a gut-derived MAMP (PDG)
results in expansion of speciﬁc mucosal immune cells (ie,
regulatory T cells).13 Because liver NPCs, including KCs
and LSECs, express many PRRs for MAMP detection,5 we
determined whether gut bacteria stimulate expansion and/or185
Figure 3 Phagocytic function and in vivo response to antigenic stimulation. A: Phagocytosis (1.22 mm magnet uptake) assay reveals that GF mice have
signiﬁcantly more phagocytic activity than CL mice (PZ 0.031). Representative of two independent experiments (nZ 3 per group). B: KC frequency in CL and
GF mice before and 24 hours after treatment with 100 ng of ﬂagellin (FLA) reveals that FLA treatment does not cause signiﬁcant differences in KC frequency.
Representative of two independent experiments (nZ 3 to 4 per group). C: Monocyte frequency (CD11bþLy6Cþ NPCs) 24 hours after FLA challenge results in
greater liver monocyte inﬂux in GF mice compared with CL mice. Representative of two independent experiments (n Z 3 to 4 per group). Adult CL, GF, and
AVMN mice were used. *P < 0.05, ***P < 0.01.
Corbitt et alrecruitment of liver immune cell populations. Results indi-
cate that nucleated sinusoidal cell number is reduced in GF
livers (PZ 0.009) (Supplemental Figure S1). However, the
absolute numbers of NPCs isolated from CL and GF livers
did not differ signiﬁcantly (6.34  1.2 million and 4.17 
1.2 million, respectively; P Z 0.28).
We, therefore, hypothesized that gut bacteria contribute to
quantitative and/or qualitative changes in the KC pop-
ulation. First, we evaluated KC frequency during adoles-
cence when the gut microbiome is not fully established (data
not shown). During adolescence, CL mice have 15.2% F4/
80þ NPCs, and GF mice have 17.11% F4/80þ NPCs,
although both CL and GF KCs are relatively immature/
inactivated as reﬂected by the insigniﬁcant major histo-
compatibility complex class II (MHCII) expression (0.5%
and 1.5% F4/80þMHCIIþ NPCs, respectively) (Figure 2A).
However, the KC population size doubles during the tran-
sition from adolescence to young adulthood in CL mice,Figure 4 Germ status does not change PRR expression. TLR-2, -4, -5, and -9 e
treatment (dashed line) with 100 ng of ﬂagellin revealed no change in TLR expre
two independent experiments (n Z 3 to 4 per group). Adult CL and GF mice wer
186whereas KC frequency in GF age-matched counterparts
remains unchanged (32% and 14% F4/80þ NPCs in CL and
GF adults, respectively) (Figure 2C). Moreover, adult CL
mice have a signiﬁcant population of MHCIIþ KCs (14.4%
NPCs), whereas adult GF mice (7.4% F4/80þMHCIIþ
NPCs) resemble their juvenile counterparts (Figure 2C and
Supplemental Figure S2).
Perplexed by the variability in CL KC frequency
compared with GF KC frequency, we hypothesized that the
former might be related to the aforementioned differences in
gut bacterial loads among CL mice (Figure 1B). Results
indicated that the number of mature KCs (F4/80þMHCIIþ
NPCs) is directly related to gut bacterial load (P Z 0.024)
(Figure 2B). If more gut bacteria are associated with higher
KC numbers, then less gut bacteria should result in lower
KC numbers. As expected, AVMN mice had a signiﬁcant
reduction in KCs compared with CL mice (3.5% and 20.4%
NPCs in AVMN and CL mice, respectively) and lose/fail toxpression on KCs from CL and GF mice before (solid line) or 24 hours after
ssion. Isotype controls are shown in gray. Histograms are representative of
e used.
ajp.amjpathol.org - The American Journal of Pathology
Figure 5 KC progenitor development is independent of gut bacteria. A:
Relative expression of monocyte colony-stimulating factor (csf1) (analysis
of variance, P Z 0.50) and granulocyte-monocyte colony-stimulating
factor (csf2) (analysis of variance, PZ 0.84) mRNA revealed no signiﬁcant
differences among the mouse groups. Black line represents mean expres-
sion, with Hrpt1 used as an internal control [nZ 4 in the CL group (white
circle), nZ 4 in the AVMN group (gray circle), and nZ 4 in the GF group
(black circle)]. B: KC progenitors in the livers of CL, GF, and AVMN mice
(analysis of variance, P Z 0.663) revealed no difference among groups.
Representative of three independent experiments (n Z 3 to 6 in the CL
group, nZ 3 to 5 in the GF group, and nZ 3 to 4 in the AVMN group). C:
KC progenitors in systemic circulation (percentage of PBMCs) in CL and GF
mice were not signiﬁcantly different; CD11bþLy6Cþ PBMCs (lined gate)
(P Z 0.27). Circulating CD11b-Ly6Cþ PBMC counts (arrow) were signiﬁ-
cantly lower in GF mice (n Z 6 in the CL group; n Z 6 in the GF group).
D: KC progenitors in bone marrow (percentage of MDCs) in CL (nZ 6) and
GF (nZ 6) mice were not signiﬁcantly different (PZ 0.37); CD11bþLy6Cþ
BMDCs (lined gate). CL, GF, and AVMN mice were used. ***P < 0.01.
MAMPs Drive Kupffer Cell Accumulationdevelop the population of MHCIIþ KCs (0.6% and 13.5%
NPCs in AVMN and CL mice, respectively) (Figure 2D).
Twice as many KCs are located in the periportal compared
with the centrilobular sinusoids.14 We therefore determined
whether the KC deﬁciency observed in GF and AVMN mice
was global or regional. CLmice exhibited three times asmany
KCs in the periportal regions (34.4  8.9 cells/0.1 mm2)
compared with the centrilobular regions (10.3 3.0 cells/0.1
mm2), but GF and AVMN mice exhibited both reduced per-
iportal (6.3  4.2 cells/0.1 mm2 and 20  2.5 cells/0.1 mm2)
and centrilobular (2.8 2.2 cells/0.1mm2 and 5.5 1.0 cells/
0.1mm2) numbers, respectively (Figure 2E and Supplemental
Figure S3), although the greatest differences were seen in the
periportal areas. The change in KC frequency could not be
attributed to differences in liver size (P Z 0.14, analysis of
variance) (Supplemental Figure S4), lobular size (data not
shown), or macrophage proliferation alone as assessed by Ki-
67 expression (Supplemental Figure S5).The American Journal of Pathology - ajp.amjpathol.orgGut Bacteria Affect KC Phenotype and Function
KCs link innate and adaptive immunity by interacting with
MAMPs and circulating lymphocytes in the hepatic sinusoid
via MHCII presentation of antigenic epitopes after endocy-
tosis of circulating antigens.15 Loading of MHC molecules
with antigenic peptide is often followed by up-regulation of
co-stimulatory molecules CD80 and CD86.16 Because
MHCII expression increased with higher bacterial loads
(Figure 2, C and D), we next assessed expression of co-
stimulatory molecules CD80 and CD86 on KC and phago-
cytic function (part of exogenous pathway of antigen
presentation). Results revealed no signiﬁcant differences in
CD80/CD86 expression when comparing KCs from CL, GF,
and AVMN mice, although KCs in GF and AVMN mice
consistently expressed modestly lower levels (Supplemental
Figure S6).
Because KCs characteristically exhibit low levels of
co-stimulatory molecules compared with other professional
antigen presentation cells,17 we assessed co-stimulatory
molecule expression after ﬂagellin stimulation, which is
the most highly detectable MAMP found in both portal and
systemic blood (Figure 1, C and E). Flagellin stimulation
did not signiﬁcantly increase or decrease co-stimulatory
molecule expression by CL or GF KCs (Supplemental
Figure S7).
We next evaluated in vivo phagocytic activity by deter-
mining the number of active nonendothelial phagocytes
after magnetic isolation of cells containing micromagnets
(1.22 mm). The percentage of active phagocytes was 5.4%
(54,716 phagocytes per million NPCs) in CL livers versus
9.7% (97,000 phagocytes per million NPCs) in GF livers
(Figure 3A). The signiﬁcantly increased phagocytic activity
in GF mice suggests that MAMP exposure reduces envi-
ronmental sampling, although overall collective environ-
mental sampling might be maintained in CL mice due to
increased KC numbers.
Because LPS can stimulate KC expansion,18 we deter-
mined whether ﬂagellin (the most highly detectable MAMP
in portal circulation) generated a CL phenotype in GF livers
(Figure 3B). Neither total KC (F4/80þ NPCs) nor mature
KC frequency (F4/80þMHCIIþ NPCs) were altered by
ﬂagellin stimulation at physiologic concentration within the
limitations of a 24-hour time course (ensuring no outside
inﬂuence from environmental exposures to the GF mice).
KC progenitor (monocyte) frequency, however, in GF livers
nearly doubled that of CL livers after ﬂagellin challenge
(Figure 3C).
Constitutive MAMP Exposure Does Not Change PRR
Expression by KCs
PRRs are conserved germline-encoded receptors,17 but
expression levels of some PRRs (ie, TLR-4) can increase
in response to stimulation.5 KCs express many PRRs
constitutively (TLR-2, TLR-4, TLR-5, TLR-9, and187
Figure 6 Constitutive ICAM-1 expression by LSECs is induced by the gut microbiota and permits KC repopulation. A: ICAM-1 (red) and LYVE-1 (green)
expression on LSECs [DAPI (blue nuclear stain)]. Original magniﬁcation, 10 (representative images of liver section); 30 (representative images of portal/
central regions). Quantiﬁcation of immunoﬂuorescence area per high-power ﬁeld revealed signiﬁcantly higher ICAM-1 and LYVE-1 expression in CL mice (nZ 3
in the CL group; nZ 3 in the GF group). Five ﬁelds per region per mouse for a total of 15 images per group were used for analysis. ***P < 0.01. B: Western
blot reveals higher hepatic ICAM-1 expression in CL mice compared with GF and AVMN mice (nZ 3). C: Injection scheme for repopulation model; CL2MDP was
used to deplete KCs on day 0. Either ICAM-1 or LYVE-1 blockade was performed on day 3 after KC depletion. KC and monocyte frequency was assessed by ﬂow
cytometry on day 6 afrer KC depletion. DeE: Monocyte inﬂux (CD11bþLy6Cþ NPCs) (D) and untreated CL Swiss Webster mice were used as negative controls
(100% inﬂux). KC repopulation (F4/80þMHCIIþ NPCs) (E). Untreated CL SW mice were used as negative controls (100% repopulation). Representative of two
independent experiments (n Z 3 to 4 per group). CL, AVMN, and GF mice were used. *P < 0.05 experimental group versus negative control; yP < 0.05
experimental group versus positive control.
Corbitt et alNOD2),5 but we hypothesized that KC PRR expression
might be dependent on constitutive MAMP exposure.
Thus, TLR-2, TLR-4, TLR-5, and TLR-9 expression was
evaluated before and after ﬂagellin stimulation (Figure 4).
Results reveal that CL KC and GF KC express surface188TLR-2, TLR-4, TLR-5, and TLR-9 (Figure 4). TLR-5
expression was modestly increased in response to
ﬂagellin, but overall KC surface TLR expression did not
appear to be dependent on exposure to gut bacteria/
MAMPs (Figure 4).ajp.amjpathol.org - The American Journal of Pathology
Figure 7 Reduced KC frequency limits liver injury mediated by ischemia
reperfusion after cold storage and transplantation. A: After 24 hours of cold
preservation and 6 hours after reperfusion after orthotopic liver trans-
plantation, AVMN mice (n Z 5) had signiﬁcantly lower alanine amino-
transferase (P Z < 0.001) and aspartate aminotransferase (P Z 0.003)
levels compared with CL mice (n Z 5). B: Liver histologic analysis
conﬁrmed noticeably less injury in the AVMN mice that harbor signiﬁcantly
fewer KCs. The foci of coagulative-type necrosis were irregularly shaped
and more often located in perivenular regions (arrows). *P < 0.001,
**P < 0.01.
MAMPs Drive Kupffer Cell AccumulationClassical KC Progenitor Frequency Is Independent of
Germ Status
KCs are derived from bone marrowederived monocytes
under the inﬂuence of colony-stimulating factors as deﬁned
by the mononuclear phagocyte system.14 Therefore, the KC
deﬁciency associated with low gut bacteria could be due to
failure of KC progenitors to differentiate or deﬁciency of
KC progenitors themselves. First, macrophage-colony
stimulating factor (Csf1) and granulocyte-macrophage
colony-stimulating factor (Csf2), which drive monocyte
differentiation and promote KC survival, were not differ-
entially expressed (cDNA assessed by RT-PCR) between
CL (mean 2-DCt: csf1 0.16, csf2 0.009), AVMN (mean
2-DCt: csf1 0.02, csf2 0.01), and GF (mean 2-DCt: csf1 0.62,
csf2 0.0006) livers relative to the Hprt1 internal control
(Figure 5A). Second, monocyte frequency (percentage of
CD11bþLy6Cþ or CD11bþGR1þ cells) in the liver (<3%
of NPCs in CL, GF, and AVMN mice) (Figure 5B),
circulation (CL mice, 2.1% PBMCs; GF mice, 3.4%The American Journal of Pathology - ajp.amjpathol.orgPBMCs) (Figure 5C), and bone marrow (CL mice, 51.3%
BMDCs; GF mice, 53.4% BMDCs) (Figure 5D) were
unaffected by gut bacteria.
Notably, however, a population of circulating
CD11bLy6Cþ cells was found to be reduced in GF mice
(Figure 5C). CD11bLy6Cþ cells are not classically char-
acterized as monocytes (myeloid lineage), but there is some
plasticity within the mononuclear phagocyte system19; thus,
this cell population cannot be entirely excluded as precur-
sors to KCs or other cell types. Regardless, these ﬁndings
indicate that the frequency of intrahepatic monocytes
(classic KC progenitors) is independent of gut bacteria, and
the mobilization of monocytes from the bone marrow to
circulation is not defective. Therefore, another mechanism is
responsible for the KC deﬁciency associated with gut
bacteria deﬁcits.MAMP Exposure Induces ICAM-1 and LYVE-1 Expression
by LSECs Increasing KC Retention
Monocyte recruitment to the liver in the infectious setting is
stimulated by up-regulation of adhesion molecules on
LSECs,20 although some adhesion molecules are thought
to be constitutively expressed in the liver, including
ICAM-1.21 Thus, we determined whether basal adhesion
molecule expression is modulated by MAMPs and whether
a change in adhesion molecule expression alters KC
number. We ﬁrst examined ICAM-1 expression on LSECs
(LYVE1þ cells), but LYVE-1, an LSEC marker and adhe-
sion molecule,22 was not consistently expressed between CL
and GF mice (Figure 6A). Compared with expression in CL
mice, quantitative morphometric examination of LYVE1
expression in GF livers was reduced (Figure 6A). ICAM-1
expression was similarly reduced in GF livers, and partic-
ularly so in the centrilobular regions (Figure 6A). We
conﬁrmed by Western blotting that whole liver ICAM-1
expression was signiﬁcantly reduced in GF and AVMN
mice (P < 0.001) (Figure 6B).
A repopulation model was next used to determine whether
LYVE-1 and ICAM-1 participate in shaping the KC proﬁle
under noninfectious conditions using a liposome-entrapped
clodronate (CL2MDP) KC depletion protocol (Figure 6C).
Monocyte inﬂux and KC repopulation were tracked after
ICAM-1 or LYVE-1 blockade. Neither ICAM-1 nor LYVE-1
blockade completely limited liver monocyte trafﬁcking after
KC depletion (Figure 6D). However ICAM-1, but not LYVE-
1, blockade impeded KC repopulation (Figure 6E). ICAM-1
blockade reduced monocyte inﬂux by 53% (PZ 0.32), and
KC population was stunted by 68% (P Z 0.04). LYVE-1
blockade reduced monocyte inﬂux by 80% (PZ 0.27), and
KC population was stunted by 35% (P Z 0.41). Results
indicate that monocyte recruitment is not dependent on
ICAM-1 alone, but full restoration of the mature KC pop-
ulation after depletion appears to be ICAM-1 dependent
(Figure 6, D and E).189
Corbitt et alReduced KC Frequency Limits Hepatic Ischemia/
Reperfusion Injury after Orthotopic Liver
Transplantation
KCs can either promote or prevent liver injury, depending on
the insult and context. In hepatic ischemia/reperfusion injury
after orthotopic liver transplantation, KCs can release hepa-
totoxic mediators that promote the injury.23 For example,
activated KCs increase liver injury, whereas inactivated KCs
abrogate liver injury induced by ischemia/reperfusion
(reviewed in Shiratori et al23). We tested, therefore, the
hypothesis that reduced KC frequency and lower MHCII
expression, as seen in GF and AVMNmice, might also lessen
injury after cold preservation/reperfusion and transplantation.
As expected, KC deﬁciency secondary to gut bacteria
reduction profoundly reduces hepatocellular damage as evi-
denced by signiﬁcantly lower alanine aminotransferase and
aspartate aminotransferase levels and liver histopathologic
ﬁndings (Figure 7).AVMN-treatedmice had less coagulative-
type hepatocyte necrosis and less sinusoidal neutrophil inﬁl-
tration, particularly near the areas of necrosis, both of which
were slightly accentuated in perivenular regions.Discussion
Uniqueness of the liver as an immunologic organ resides, in
large part, in the enrichment of specialized leukocyte subsets
that are not found at the same concentrations in other
organs,24 such as the high proportion of natural killer, natural
killer T, and CD5þ B cells and the highest concentration of
macrophages (KCs) of any organ. We report that gut bacteria
and constitutive MAMP exposure via portal blood determine
KC number, MHCII expression, and phagocytic/sinusoidal
content monitoring, which in turn signiﬁcantly inﬂuence how
KCs and the liver respond to injury after cold preservation and
orthotopic transplantation.
Germline KC PRR expression, regardless of gut bacteria,
and MAMP exposure trigger KC maturation/activation
characterized by increased MHCIIþ KCs, decreased phago-
cytic activity, but persistently low co-stimulatory molecule
expression. MAMPs, therefore, help shape a relatively tol-
erogenic KC phenotype under normal conditions, which in
turn likely contributes to T-cell tolerance along with KC
secretion of IL-10 and transforming growth factor-b.25
Previous studies report that monoassociation of GF mice
with Lactobacillus delbrueckii,26 inoculation of GF rodents
with Saccharomyces cerevisiae,27 and monoassociation of
GF rats with E. coli18 all lead to increased KC numbers.
Komatsu et al21 previously reported dynamic regulation of
liver endothelial ICAM-1 expression by gut bacteria.
Increased LSEC ICAM-1 expression has been associated
with monocyte/macrophage recruitment during bacterial
infection22 and KC expansion in old age.28
We have conﬁrmed, amalgamated, and furthered previous
observations by reporting that under physiologic conditions190gut bacteria i) release a unique cocktail of MAMPs into
circulation, which up-regulate LSEC ICAM-1 expression;
ii) density directly increases KC numbers and activation/
maturational status, including a tolerogenic proﬁle; iii)
density ﬂuctuations occur naturally or can be induced via
broad-spectrum antibiotic treatment, which in turn inﬂuence
KC-dependent functions; and iv) markedly increase
susceptibility to preservation/reperfusion liver injury after
cold storage and orthotopic liver transplantation. Previous
studies in humans and rats found a direct correlation
between gut-derived bacterial products in the recipient and
the severity of preservation/reperfusion injury.29e31
Other potential inﬂuences of the gut microbiome and
MAMPs on KC function include clearance of bacteria,
phagocytosis of malignant cells, platelet aggregates, acti-
vated complement components, antigen presentation to
T cells/activation, and T-cell tolerance.32
In summary, we found a strong correlation between gut
bacterial density, which can vary widely because of bacterial
population dynamics or antibiotic treatment, and KC density
and maturational status/functionality, which in turn can
inﬂuence many aspects of hepatic pathophysiology, such
as ischemia/reperfusion injury, tolerance induction, and
bacteria/virus clearance.23,25 Continuing research, therefore,
of the effect of the quantity, quality, and relative composition
of gut bacteria on portal MAMPs and liver physiology and
pathophysiology is warranted.Supplemental Data
Supplemental material for this article can be found at http://dx.
doi.org/10.1016/j.ajpath.2012.09.010.References
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